About Avilar Therapeutics
Avilar Therapeutics is a private company based in Waltham, Massachusetts, incorporated in 2020 in Massachusetts. It has reported $75,276,164 raised in one offering on Form D since December 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 14, 2020 | Dec 17, 2020amended Feb 13, 2023 | $75,276,164fully sold | 5 | $15.0M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Avilar Therapeutics's Form D filed Feb 13, 2023.
TC
Theresa Cameron
Director
Paulina Hill
Director
Also a board member at NextPoint Therapeutics and a director at Odyssey Therapeutics.
MF
Martin Freed
Director
ST
Stephanie Tozzo
Executive officer
PG
Phil Graham
Executive officer
MD
Milind Deshpande
Director
DN
David Neafus
Executive officer
DG
Daniel Grau
President and director
AM
Adam Muzikant
Executive officer
JR
Joshua Resnick
Director